Author:
Sreih Antoine G., ,Cronin Keri,Shaw Dianne G.,Young Kalen,Burroughs Cristina,Kullman Joyce,Machireddy Kirthi,McAlear Carol A.,Merkel Peter A.
Abstract
Abstract
Background
Patients with vasculitis, a set of rare diseases, encounter delays in obtaining an accurate diagnosis which can lead to substantial morbidity and increased mortality. This study sought to describe the diagnostic journey of patients with vasculitis and identify factors associated with time to diagnosis.
Methods
Patients with vasculitis enrolled in an online registry completed a two-stage study: Stage 1: survey of open-ended questions about patients’ diagnostic journeys and perceived factors associated with rapid or delayed diagnosis; Stage 2: survey with specific questions based on data from Stage 1 and additional investigator-identified factors.
Results
375 patients with vasculitis participated in Stage 1; 456 patients participated in Stage 2. 85% of patients were seen by a healthcare provider within 3 months of the onset of symptoms. The median time to diagnosis of vasculitis was 7 months. 313/456 (73%) of patients were misdiagnosed initially. 40% of diagnoses were made in a hospital setting; 2% of diagnoses were made at a specialized vasculitis center. 60% of patients had at least 1 visit to an emergency room prior to diagnosis. Unemployment, time to travel to a medical center > 1 h, initial misdiagnosis, and delays in seeing a specialist were all associated with longer times to diagnosis. 373/456 (82%) of patients reported that a delayed diagnosis had negative consequences on their health.
Conclusion
Patients with vasculitis encounter substantial delays in achieving an accurate diagnosis and these delays are associated with negative health consequences. Both patient-related factors and healthcare-related factors are associated with diagnostic delays.
Funder
Patient-Centered Outcomes Research Institute
National Center for Advancing Translational Science (NCATS) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics(clinical),General Medicine
Reference14 articles.
1. Poulton C, Nachman P, Hu Y, McGregor J, Jennette J, Falk R, et al. Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis. Clinical Exp Rheumatol. 2013;31:S32–7.
2. Yacyshyn E, Johnson A, Rode M, Pagnoux C. Patient-driven online survey on the clinical manifestations and diagnostic delay of granulomatosis with polyangiitis. Joint Bone Spine. 2016;83(5):599–600.
3. Takala J, Kautiainen H, Malmberg H, Leirisalo-Repo M. Wegener’s granulomatosis in Finland in 1981–2000: clinical presentation and diagnostic delay. Scand J Rheumatol. 2008;37(6):435–8.
4. Prior J, Ranjbar H, Belcher J, Mackie S, Helliwell T, Liddle J, et al. Diagnostic delay for giant cell arteritis—a systematic review and meta-analysis. BMC Med. 2017;15(1):1–12.
5. Taimen, K, Mustonen A, Pirila L. The delay and costs of diagnosing systemic vasculitis in a tertiary-level clinic. Rheumatol Therapy. 2020.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献